APO Research
Talk to an analyst

APO RESEARCH · REPORT

Animal-derived Immune Globulin Products

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Animal-derived Immune Globulin Products Market Outlook and Growth Opportunities 2026

22 December 2025191 pages

Choose your research edition.

Industry ResearchAnimal-derived Immune Globulin Products Industry Research Report 2026115 pages · $2,950 USDIndustry Growth & TrendsGlobal Animal-derived Immune Globulin Products Industry Growth and Trends Forecast to 203296 pages · $3,450 USDMarket StructureGlobal Animal-derived Immune Globulin Products Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032182 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Animal-derived Immune Globulin Products Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Animal-derived Immune Globulin Products Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Animal-derived Immune Globulin Products market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Animal-derived Immune Globulin Products is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Animal-derived Immune Globulin Products is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Animal-derived Immune Globulin Products is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Animal-derived Immune Globulin Products market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Animal-derived Immune Globulin Products market include Sanofi, Merck & Co, Pfizer, Rare Disease Therapeutics, BTG Specialty Pharmaceuticals and Bioclon Institute, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Animal-derived Immune Globulin Products market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Animal-derived Immune Globulin Products and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Animal-derived Immune Globulin Products sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Animal-derived Immune Globulin Products market size, projected growth trends, production technologies, key applications, and end-use industries.

Animal-derived Immune Globulin Products Segment by Company

Sanofi

Merck & Co

Pfizer

Rare Disease Therapeutics

BTG Specialty Pharmaceuticals

Bioclon Institute

Animal-derived Immune Globulin Products Segment by Type

IVIg Liquid

IVIg Powder

Animal-derived Immune Globulin Products Segment by Application

Autoimmune Disease

Immunodeficiency

Acute Infection

Animal-derived Immune Globulin Products Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Animal-derived Immune Globulin Products status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Animal-derived Immune Globulin Products market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Animal-derived Immune Globulin Products significant trends, drivers, influence factors in global and regions.

6. To analyze Animal-derived Immune Globulin Products competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Animal-derived Immune Globulin Products market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Animal-derived Immune Globulin Products and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Animal-derived Immune Globulin Products.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Animal-derived Immune Globulin Products market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Animal-derived Immune Globulin Products industry.

Chapter 3: Detailed analysis of Animal-derived Immune Globulin Products manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Animal-derived Immune Globulin Products in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Animal-derived Immune Globulin Products in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Animal-derived Immune Globulin Products Industry Trends Table 2. Animal-derived Immune Globulin Products Industry Drivers Table 3. Animal-derived Immune Globulin Products Industry Opportunities and Challenges Table 4. Animal-derived Immune Globulin Products Industry Restraints Table 5. Global Animal-derived Immune Globulin Products Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Animal-derived Immune Globulin Products Revenue Share by Company (2021-2026) Table 7. Global Animal-derived Immune Globulin Products Sales Volume by Company (units) & (2021-2026) Table 8. Global Animal-derived Immune Globulin Products Sales Volume Share by Company (2021-2026) Table 9. Global Animal-derived Immune Globulin Products Average Price (US$/unit) of Company (2021-2026) Table 10. Global Animal-derived Immune Globulin Products Company Ranking, (2024-2026) & (USD Million) Table 11. Global Animal-derived Immune Globulin Products Key Company Manufacturing Base & Headquarters Table 12. Global Animal-derived Immune Globulin Products Company, Product Type & Application Table 13. Global Animal-derived Immune Globulin Products Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Animal-derived Immune Globulin Products by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of IVIg Liquid Table 18. Significant Companies of IVIg Powder Table 19. Global Animal-derived Immune Globulin Products Sales Volume by Type 2021 VS 2025 VS 2032 (units) Table 20. Global Animal-derived Immune Globulin Products Sales Volume by Type (2021-2026) & (units) Table 21. Global Animal-derived Immune Globulin Products Sales Volume by Type (2027-2032) & (units) Table 22. Global Animal-derived Immune Globulin Products Sales Volume Share by Type (2021-2026) Table 23. Global Animal-derived Immune Globulin Products Sales Volume Share by Type (2027-2032) Table 24. Global Animal-derived Immune Globulin Products Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Animal-derived Immune Globulin Products Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Animal-derived Immune Globulin Products Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Animal-derived Immune Globulin Products Sales Value Share by Type (2021-2026) Table 28. Global Animal-derived Immune Globulin Products Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Autoimmune Disease Table 30. Significant Companies of Immunodeficiency Table 31. Significant Companies of Acute Infection Table 32. Global Animal-derived Immune Globulin Products Sales Volume by Application 2021 VS 2025 VS 2032 (units) Table 33. Global Animal-derived Immune Globulin Products Sales Volume by Application (2021-2026) & (units) Table 34. Global Animal-derived Immune Globulin Products Sales Volume by Application (2027-2032) & (units) Table 35. Global Animal-derived Immune Globulin Products Sales Volume Share by Application (2021-2026) Table 36. Global Animal-derived Immune Globulin Products Sales Volume Share by Application (2027-2032) Table 37. Global Animal-derived Immune Globulin Products Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Animal-derived Immune Globulin Products Sales Value by Application (2021-2026) & (US$ Million) Table 39. Global Animal-derived Immune Globulin Products Sales Value by Application (2027-2032) & (US$ Million) Table 40. Global Animal-derived Immune Globulin Products Sales Value Share by Application (2021-2026) Table 41. Global Animal-derived Immune Globulin Products Sales Value Share by Application (2027-2032) Table 42. Global Animal-derived Immune Globulin Products Sales by Region: 2021 VS 2025 VS 2032 (units) Table 43. Global Animal-derived Immune Globulin Products Sales by Region (2021-2026) & (units) Table 44. Global Animal-derived Immune Globulin Products Sales Market Share by Region (2021-2026) Table 45. Global Animal-derived Immune Globulin Products Sales by Region (2027-2032) & (units) Table 46. Global Animal-derived Immune Globulin Products Sales Market Share by Region (2027-2032) Table 47. Global Animal-derived Immune Globulin Products Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Animal-derived Immune Globulin Products Sales Value by Region (2021-2026) & (US$ Million) Table 49. Global Animal-derived Immune Globulin Products Sales Value Share by Region (2021-2026) Table 50. Global Animal-derived Immune Globulin Products Sales Value by Region (2027-2032) & (US$ Million) Table 51. Global Animal-derived Immune Globulin Products Sales Value Share by Region (2027-2032) Table 52. Global Animal-derived Immune Globulin Products Market Average Price (US$/unit) by Region (2021-2026) Table 53. Global Animal-derived Immune Globulin Products Market Average Price (US$/unit) by Region (2027-2032) Table 54. Global Animal-derived Immune Globulin Products Sales by Country: 2021 VS 2025 VS 2032 (units) Table 55. Global Animal-derived Immune Globulin Products Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 56. Global Animal-derived Immune Globulin Products Sales by Country (2021-2026) & (units) Table 57. Global Animal-derived Immune Globulin Products Sales Market Share by Country (2021-2026) Table 58. Global Animal-derived Immune Globulin Products Sales by Country (2027-2032) & (units) Table 59. Global Animal-derived Immune Globulin Products Sales Market Share by Country (2027-2032) Table 60. Global Animal-derived Immune Globulin Products Sales Value by Country (2021-2026) & (US$ Million) Table 61. Global Animal-derived Immune Globulin Products Sales Value Market Share by Country (2021-2026) Table 62. Global Animal-derived Immune Globulin Products Sales Value by Country (2027-2032) & (US$ Million) Table 63. Global Animal-derived Immune Globulin Products Sales Value Market Share by Country (2027-2032) Table 64. Sanofi Company Information Table 65. Sanofi Business Overview Table 66. Sanofi Animal-derived Immune Globulin Products Sales (units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 67. Sanofi Animal-derived Immune Globulin Products Product Portfolio Table 68. Sanofi Recent Development Table 69. Merck & Co Company Information Table 70. Merck & Co Business Overview Table 71. Merck & Co Animal-derived Immune Globulin Products Sales (units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 72. Merck & Co Animal-derived Immune Globulin Products Product Portfolio Table 73. Merck & Co Recent Development Table 74. Pfizer Company Information Table 75. Pfizer Business Overview Table 76. Pfizer Animal-derived Immune Globulin Products Sales (units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 77. Pfizer Animal-derived Immune Globulin Products Product Portfolio Table 78. Pfizer Recent Development Table 79. Rare Disease Therapeutics Company Information Table 80. Rare Disease Therapeutics Business Overview Table 81. Rare Disease Therapeutics Animal-derived Immune Globulin Products Sales (units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 82. Rare Disease Therapeutics Animal-derived Immune Globulin Products Product Portfolio Table 83. Rare Disease Therapeutics Recent Development Table 84. BTG Specialty Pharmaceuticals Company Information Table 85. BTG Specialty Pharmaceuticals Business Overview Table 86. BTG Specialty Pharmaceuticals Animal-derived Immune Globulin Products Sales (units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 87. BTG Specialty Pharmaceuticals Animal-derived Immune Globulin Products Product Portfolio Table 88. BTG Specialty Pharmaceuticals Recent Development Table 89. Bioclon Institute Company Information Table 90. Bioclon Institute Business Overview Table 91. Bioclon Institute Animal-derived Immune Globulin Products Sales (units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 92. Bioclon Institute Animal-derived Immune Globulin Products Product Portfolio Table 93. Bioclon Institute Recent Development Table 94. Key Raw Materials Table 95. Raw Materials Key Suppliers Table 96. Animal-derived Immune Globulin Products Distributors List Table 97. Animal-derived Immune Globulin Products Customers List Table 98. Research Programs/Design for This Report Table 99. Authors List of This Report Table 100. Secondary Sources Table 101. Primary Sources List of Figures Figure 1. Animal-derived Immune Globulin Products Product Image Figure 2. Global Animal-derived Immune Globulin Products Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Animal-derived Immune Globulin Products Sales Value (2021-2032) & (US$ Million) Figure 4. Global Animal-derived Immune Globulin Products Sales (2021-2032) & (units) Figure 5. Global Animal-derived Immune Globulin Products Sales Average Price (US$/unit) & (2021-2032) Figure 6. Global Animal-derived Immune Globulin Products Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. IVIg Liquid Image Figure 10. IVIg Powder Image Figure 11. Global Animal-derived Immune Globulin Products Sales Volume by Type (2021 VS 2025 VS 2032) & (units) Figure 12. Global Animal-derived Immune Globulin Products Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Animal-derived Immune Globulin Products Sales Volume Share by Type (2021-2032) Figure 14. Global Animal-derived Immune Globulin Products Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Animal-derived Immune Globulin Products Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Animal-derived Immune Globulin Products Sales Value Share by Type (2021-2032) Figure 17. Autoimmune Disease Image Figure 18. Immunodeficiency Image Figure 19. Acute Infection Image Figure 20. Global Animal-derived Immune Globulin Products Sales Volume by Application (2021 VS 2025 VS 2032) & (units) Figure 21. Global Animal-derived Immune Globulin Products Sales Volume Share 2021 VS 2025 VS 2032 Figure 22. Global Animal-derived Immune Globulin Products Sales Volume Share by Application (2021-2032) Figure 23. Global Animal-derived Immune Globulin Products Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Animal-derived Immune Globulin Products Sales Value Share 2021 VS 2025 VS 2032 Figure 25. Global Animal-derived Immune Globulin Products Sales Value Share by Application (2021-2032) Figure 26. Global Animal-derived Immune Globulin Products Sales by Region: 2021 VS 2025 VS 2032 (units) Figure 27. Global Animal-derived Immune Globulin Products Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global Animal-derived Immune Globulin Products Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global Animal-derived Immune Globulin Products Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America Animal-derived Immune Globulin Products Sales Value (2021-2032) & (US$ Million) Figure 31. North America Animal-derived Immune Globulin Products Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Europe Animal-derived Immune Globulin Products Sales Value (2021-2032) & (US$ Million) Figure 33. Europe Animal-derived Immune Globulin Products Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Asia-Pacific Animal-derived Immune Globulin Products Sales Value (2021-2032) & (US$ Million) Figure 35. Asia-Pacific Animal-derived Immune Globulin Products Sales Value Share by Country (%), 2025 VS 2032 Figure 36. South America Animal-derived Immune Globulin Products Sales Value (2021-2032) & (US$ Million) Figure 37. South America Animal-derived Immune Globulin Products Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Middle East & Africa Animal-derived Immune Globulin Products Sales Value (2021-2032) & (US$ Million) Figure 39. Middle East & Africa Animal-derived Immune Globulin Products Sales Value Share by Country (%), 2025 VS 2032 Figure 40. USA Animal-derived Immune Globulin Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. USA Animal-derived Immune Globulin Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. USA Animal-derived Immune Globulin Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Canada Animal-derived Immune Globulin Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Canada Animal-derived Immune Globulin Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Canada Animal-derived Immune Globulin Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Mexico Animal-derived Immune Globulin Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Mexico Animal-derived Immune Globulin Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Mexico Animal-derived Immune Globulin Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Germany Animal-derived Immune Globulin Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Germany Animal-derived Immune Globulin Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Germany Animal-derived Immune Globulin Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. France Animal-derived Immune Globulin Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. France Animal-derived Immune Globulin Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. France Animal-derived Immune Globulin Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. U.K. Animal-derived Immune Globulin Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. U.K. Animal-derived Immune Globulin Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. U.K. Animal-derived Immune Globulin Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Italy Animal-derived Immune Globulin Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Italy Animal-derived Immune Globulin Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Italy Animal-derived Immune Globulin Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Spain Animal-derived Immune Globulin Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Spain Animal-derived Immune Globulin Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Spain Animal-derived Immune Globulin Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Russia Animal-derived Immune Globulin Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Russia Animal-derived Immune Globulin Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Russia Animal-derived Immune Globulin Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Netherlands Animal-derived Immune Globulin Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Netherlands Animal-derived Immune Globulin Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Netherlands Animal-derived Immune Globulin Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Nordic Countries Animal-derived Immune Globulin Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Nordic Countries Animal-derived Immune Globulin Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Nordic Countries Animal-derived Immune Globulin Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. China Animal-derived Immune Globulin Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. China Animal-derived Immune Globulin Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. China Animal-derived Immune Globulin Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Japan Animal-derived Immune Globulin Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Japan Animal-derived Immune Globulin Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Japan Animal-derived Immune Globulin Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. South Korea Animal-derived Immune Globulin Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. South Korea Animal-derived Immune Globulin Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. South Korea Animal-derived Immune Globulin Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. India Animal-derived Immune Globulin Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. India Animal-derived Immune Globulin Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. India Animal-derived Immune Globulin Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Australia Animal-derived Immune Globulin Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Australia Animal-derived Immune Globulin Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Australia Animal-derived Immune Globulin Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Southeast Asia Animal-derived Immune Globulin Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Southeast Asia Animal-derived Immune Globulin Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Southeast Asia Animal-derived Immune Globulin Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Brazil Animal-derived Immune Globulin Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Brazil Animal-derived Immune Globulin Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Brazil Animal-derived Immune Globulin Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Argentina Animal-derived Immune Globulin Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Argentina Animal-derived Immune Globulin Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Argentina Animal-derived Immune Globulin Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Chile Animal-derived Immune Globulin Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Chile Animal-derived Immune Globulin Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Chile Animal-derived Immune Globulin Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Colombia Animal-derived Immune Globulin Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Colombia Animal-derived Immune Globulin Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Colombia Animal-derived Immune Globulin Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Peru Animal-derived Immune Globulin Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Peru Animal-derived Immune Globulin Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Peru Animal-derived Immune Globulin Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Saudi Arabia Animal-derived Immune Globulin Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Saudi Arabia Animal-derived Immune Globulin Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Animal-derived Immune Globulin Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Israel Animal-derived Immune Globulin Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Israel Arabia Animal-derived Immune Globulin Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Israel Arabia Animal-derived Immune Globulin Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. UAE Animal-derived Immune Globulin Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. UAE Animal-derived Immune Globulin Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. UAE Animal-derived Immune Globulin Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Turkey Animal-derived Immune Globulin Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Turkey Animal-derived Immune Globulin Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Turkey Animal-derived Immune Globulin Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Iran Animal-derived Immune Globulin Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Iran Animal-derived Immune Globulin Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Iran Animal-derived Immune Globulin Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Egypt Animal-derived Immune Globulin Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Egypt Animal-derived Immune Globulin Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Egypt Animal-derived Immune Globulin Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Animal-derived Immune Globulin Products Value Chain Figure 125. Manufacturing Cost Structure Figure 126. Animal-derived Immune Globulin Products Sales Mode & Process Figure 127. Direct Comparison with Distribution Share Figure 128. Distributors Profiles Figure 129. Years Considered Figure 130. Research Process Figure 131. Key Executives Interviewed

Scope & coverage.

Types
  • IVIg Liquid
  • IVIg Powder
Applications
  • Autoimmune Disease
  • Immunodeficiency
  • Acute Infection
Companies covered
  • Sanofi
  • Merck & Co
  • Pfizer
  • Rare Disease Therapeutics
  • BTG Specialty Pharmaceuticals
  • Bioclon Institute

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Animal-derived Immune Globulin Products Sales Value (2021-2032)
  4. 1.2.2 Global Animal-derived Immune Globulin Products Sales Volume (2021-2032)
  5. 1.2.3 Global Animal-derived Immune Globulin Products Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Animal-derived Immune Globulin Products Market Dynamics
  1. 2.1 Animal-derived Immune Globulin Products Industry Trends
  2. 2.2 Animal-derived Immune Globulin Products Industry Drivers
  3. 2.3 Animal-derived Immune Globulin Products Industry Opportunities and Challenges
  4. 2.4 Animal-derived Immune Globulin Products Industry Restraints
3 Animal-derived Immune Globulin Products Market by Company
  1. 3.1 Global Animal-derived Immune Globulin Products Company Revenue Ranking in 2025
  2. 3.2 Global Animal-derived Immune Globulin Products Revenue by Company (2021-2026)
  3. 3.3 Global Animal-derived Immune Globulin Products Sales Volume by Company (2021-2026)
  4. 3.4 Global Animal-derived Immune Globulin Products Average Price by Company (2021-2026)
  5. 3.5 Global Animal-derived Immune Globulin Products Company Ranking (2024-2026)
  6. 3.6 Global Animal-derived Immune Globulin Products Company Manufacturing Base and Headquarters
  7. 3.7 Global Animal-derived Immune Globulin Products Company Product Type and Application
  8. 3.8 Global Animal-derived Immune Globulin Products Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Animal-derived Immune Globulin Products Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Animal-derived Immune Globulin Products Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Animal-derived Immune Globulin Products Market by Type
  1. 4.1 Animal-derived Immune Globulin Products Type Introduction
  2. 4.1.1 IVIg Liquid
  3. 4.1.2 IVIg Powder
  4. 4.2 Global Animal-derived Immune Globulin Products Sales Volume by Type
  5. 4.2.1 Global Animal-derived Immune Globulin Products Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Animal-derived Immune Globulin Products Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Animal-derived Immune Globulin Products Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Animal-derived Immune Globulin Products Sales Value by Type
  9. 4.3.1 Global Animal-derived Immune Globulin Products Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Animal-derived Immune Globulin Products Sales Value by Type (2021-2032)
  11. 4.3.3 Global Animal-derived Immune Globulin Products Sales Value Share by Type (2021-2032)
5 Animal-derived Immune Globulin Products Market by Application
  1. 5.1 Animal-derived Immune Globulin Products Application Introduction
  2. 5.1.1 Autoimmune Disease
  3. 5.1.2 Immunodeficiency
  4. 5.1.3 Acute Infection
  5. 5.2 Global Animal-derived Immune Globulin Products Sales Volume by Application
  6. 5.2.1 Global Animal-derived Immune Globulin Products Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Animal-derived Immune Globulin Products Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Animal-derived Immune Globulin Products Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Animal-derived Immune Globulin Products Sales Value by Application
  10. 5.3.1 Global Animal-derived Immune Globulin Products Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Animal-derived Immune Globulin Products Sales Value by Application (2021-2032)
  12. 5.3.3 Global Animal-derived Immune Globulin Products Sales Value Share by Application (2021-2032)
6 Animal-derived Immune Globulin Products Regional Sales and Value Analysis
  1. 6.1 Global Animal-derived Immune Globulin Products Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Animal-derived Immune Globulin Products Sales by Region (2021-2032)
  3. 6.2.1 Global Animal-derived Immune Globulin Products Sales by Region: 2021-2026
  4. 6.2.2 Global Animal-derived Immune Globulin Products Sales by Region (2027-2032)
  5. 6.3 Global Animal-derived Immune Globulin Products Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Animal-derived Immune Globulin Products Sales Value by Region (2021-2032)
  7. 6.4.1 Global Animal-derived Immune Globulin Products Sales Value by Region: 2021-2026
  8. 6.4.2 Global Animal-derived Immune Globulin Products Sales Value by Region (2027-2032)
  9. 6.5 Global Animal-derived Immune Globulin Products Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Animal-derived Immune Globulin Products Sales Value (2021-2032)
  12. 6.6.2 North America Animal-derived Immune Globulin Products Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Animal-derived Immune Globulin Products Sales Value (2021-2032)
  15. 6.7.2 Europe Animal-derived Immune Globulin Products Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Animal-derived Immune Globulin Products Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Animal-derived Immune Globulin Products Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Animal-derived Immune Globulin Products Sales Value (2021-2032)
  21. 6.9.2 South America Animal-derived Immune Globulin Products Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Animal-derived Immune Globulin Products Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Animal-derived Immune Globulin Products Sales Value Share by Country, 2025 VS 2032
7 Animal-derived Immune Globulin Products Country-level Sales and Value Analysis
  1. 7.1 Global Animal-derived Immune Globulin Products Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Animal-derived Immune Globulin Products Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Animal-derived Immune Globulin Products Sales by Country (2021-2032)
  4. 7.3.1 Global Animal-derived Immune Globulin Products Sales by Country (2021-2026)
  5. 7.3.2 Global Animal-derived Immune Globulin Products Sales by Country (2027-2032)
  6. 7.4 Global Animal-derived Immune Globulin Products Sales Value by Country (2021-2032)
  7. 7.4.1 Global Animal-derived Immune Globulin Products Sales Value by Country (2021-2026)
  8. 7.4.2 Global Animal-derived Immune Globulin Products Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Animal-derived Immune Globulin Products Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Animal-derived Immune Globulin Products Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Animal-derived Immune Globulin Products Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Animal-derived Immune Globulin Products Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Animal-derived Immune Globulin Products Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Animal-derived Immune Globulin Products Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Animal-derived Immune Globulin Products Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Animal-derived Immune Globulin Products Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Animal-derived Immune Globulin Products Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Animal-derived Immune Globulin Products Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Animal-derived Immune Globulin Products Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Animal-derived Immune Globulin Products Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Animal-derived Immune Globulin Products Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Animal-derived Immune Globulin Products Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Animal-derived Immune Globulin Products Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Animal-derived Immune Globulin Products Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Animal-derived Immune Globulin Products Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Animal-derived Immune Globulin Products Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Animal-derived Immune Globulin Products Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Animal-derived Immune Globulin Products Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Animal-derived Immune Globulin Products Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Animal-derived Immune Globulin Products Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Animal-derived Immune Globulin Products Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Animal-derived Immune Globulin Products Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Animal-derived Immune Globulin Products Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Animal-derived Immune Globulin Products Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Animal-derived Immune Globulin Products Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Animal-derived Immune Globulin Products Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Animal-derived Immune Globulin Products Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Animal-derived Immune Globulin Products Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Animal-derived Immune Globulin Products Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Animal-derived Immune Globulin Products Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Animal-derived Immune Globulin Products Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Animal-derived Immune Globulin Products Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Animal-derived Immune Globulin Products Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Animal-derived Immune Globulin Products Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Animal-derived Immune Globulin Products Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Animal-derived Immune Globulin Products Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Animal-derived Immune Globulin Products Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Animal-derived Immune Globulin Products Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Animal-derived Immune Globulin Products Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Animal-derived Immune Globulin Products Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Animal-derived Immune Globulin Products Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Animal-derived Immune Globulin Products Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Animal-derived Immune Globulin Products Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Animal-derived Immune Globulin Products Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Animal-derived Immune Globulin Products Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Animal-derived Immune Globulin Products Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Animal-derived Immune Globulin Products Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Animal-derived Immune Globulin Products Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Animal-derived Immune Globulin Products Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Animal-derived Immune Globulin Products Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Animal-derived Immune Globulin Products Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Animal-derived Immune Globulin Products Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Animal-derived Immune Globulin Products Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Animal-derived Immune Globulin Products Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Animal-derived Immune Globulin Products Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Animal-derived Immune Globulin Products Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Animal-derived Immune Globulin Products Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Animal-derived Immune Globulin Products Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Animal-derived Immune Globulin Products Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Animal-derived Immune Globulin Products Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Animal-derived Immune Globulin Products Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Animal-derived Immune Globulin Products Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Animal-derived Immune Globulin Products Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Animal-derived Immune Globulin Products Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Animal-derived Immune Globulin Products Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Animal-derived Immune Globulin Products Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Animal-derived Immune Globulin Products Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Animal-derived Immune Globulin Products Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Animal-derived Immune Globulin Products Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Animal-derived Immune Globulin Products Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Animal-derived Immune Globulin Products Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Animal-derived Immune Globulin Products Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Animal-derived Immune Globulin Products Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Animal-derived Immune Globulin Products Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Animal-derived Immune Globulin Products Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Animal-derived Immune Globulin Products Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Animal-derived Immune Globulin Products Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Animal-derived Immune Globulin Products Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Animal-derived Immune Globulin Products Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Animal-derived Immune Globulin Products Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Animal-derived Immune Globulin Products Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Animal-derived Immune Globulin Products Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Sanofi
  2. 8.1.1 Sanofi Company Information
  3. 8.1.2 Sanofi Business Overview
  4. 8.1.3 Sanofi Animal-derived Immune Globulin Products Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Sanofi Animal-derived Immune Globulin Products Product Portfolio
  6. 8.1.5 Sanofi Recent Developments
  7. 8.2 Merck & Co
  8. 8.2.1 Merck & Co Company Information
  9. 8.2.2 Merck & Co Business Overview
  10. 8.2.3 Merck & Co Animal-derived Immune Globulin Products Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Merck & Co Animal-derived Immune Globulin Products Product Portfolio
  12. 8.2.5 Merck & Co Recent Developments
  13. 8.3 Pfizer
  14. 8.3.1 Pfizer Company Information
  15. 8.3.2 Pfizer Business Overview
  16. 8.3.3 Pfizer Animal-derived Immune Globulin Products Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Pfizer Animal-derived Immune Globulin Products Product Portfolio
  18. 8.3.5 Pfizer Recent Developments
  19. 8.4 Rare Disease Therapeutics
  20. 8.4.1 Rare Disease Therapeutics Company Information
  21. 8.4.2 Rare Disease Therapeutics Business Overview
  22. 8.4.3 Rare Disease Therapeutics Animal-derived Immune Globulin Products Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Rare Disease Therapeutics Animal-derived Immune Globulin Products Product Portfolio
  24. 8.4.5 Rare Disease Therapeutics Recent Developments
  25. 8.5 BTG Specialty Pharmaceuticals
  26. 8.5.1 BTG Specialty Pharmaceuticals Company Information
  27. 8.5.2 BTG Specialty Pharmaceuticals Business Overview
  28. 8.5.3 BTG Specialty Pharmaceuticals Animal-derived Immune Globulin Products Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 BTG Specialty Pharmaceuticals Animal-derived Immune Globulin Products Product Portfolio
  30. 8.5.5 BTG Specialty Pharmaceuticals Recent Developments
  31. 8.6 Bioclon Institute
  32. 8.6.1 Bioclon Institute Company Information
  33. 8.6.2 Bioclon Institute Business Overview
  34. 8.6.3 Bioclon Institute Animal-derived Immune Globulin Products Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Bioclon Institute Animal-derived Immune Globulin Products Product Portfolio
  36. 8.6.5 Bioclon Institute Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Animal-derived Immune Globulin Products Value Chain Analysis
  2. 9.1.1 Animal-derived Immune Globulin Products Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Animal-derived Immune Globulin Products Sales Mode & Process
  6. 9.2 Animal-derived Immune Globulin Products Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Animal-derived Immune Globulin Products Distributors
  9. 9.2.3 Animal-derived Immune Globulin Products Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst